G01N 2800/347
Renal failures
Official title: Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
G01N2800/347 (Renal failures) appears on 493 US grants and 1,142 published applications in this corpus.
Search patents in G01N- Granted patents
- 493
- Published applications
- 1,142
- Assignees
- 545
- Inventors
- 1,857
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 8 |
| 2004 | 0 | 11 |
| 2005 | 5 | 13 |
| 2006 | 10 | 20 |
| 2007 | 4 | 16 |
| 2008 | 1 | 23 |
| 2009 | 8 | 29 |
| 2010 | 12 | 53 |
| 2011 | 11 | 75 |
| 2012 | 19 | 68 |
| 2013 | 22 | 78 |
| 2014 | 22 | 60 |
| 2015 | 25 | 61 |
| 2016 | 33 | 73 |
| 2017 | 39 | 79 |
| 2018 | 22 | 57 |
| 2019 | 40 | 56 |
| 2020 | 44 | 63 |
| 2021 | 40 | 70 |
| 2022 | 28 | 57 |
| 2023 | 20 | 50 |
| 2024 | 31 | 48 |
| 2025 | 28 | 47 |
| 2026 | 20 | 27 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for diagnosing and treating chronic kidney disease14 Jul 2026US 12,681,023 B2Societe des Produits Nestle S. A.
- Isolated antigen binding protein binding to a complement protein C5 and a method of detecting thereof16 Jun 2026US 12,655,201 B2Longbio Pharma (Suzhou) Co., Ltd.
- Ergothioneine, S-methyl-ergothioneine, and uses thereof9 Jun 2026US 12,648,932 B2Consorcio Centro de Investigación Biomédica en Red, M. P.
- Human IgG autoantibodies against galactose-deficient IgA1, preparation method thereof, and use thereof9 Jun 2026US 12,650,431 B2National Defense Medical University
- Kidney health monitoring in hypertension patients26 May 2026US 12,638,455 B2The Regents of the University of California
- Quantitative immunoassay for the detection of autoantibodies to nephrin1 Oct 2026US 2026/0298924 A1EUROIMMUN Medizinische Labordiagnostika AG
- Prognostic and predictive value of endothelial dysfunction biomarkers in sepsis-associated acute kidney injury24 Sep 2026US 2026/0287596 A1Children's Hospital Medical Center
- Method for examining feline renal dysfunction17 Sep 2026US 2026/0276649 A1Kao Corporation
- Method for obtaining information on renal amyloidosis, method for assisting diagnosis of renal amyloidosis, and reagent kit10 Sep 2026US 2026/0266846 A1National University Corporation Kumamoto University
- Targeting aberrant o-glycans of iga1 to develop a urinary diagnostic method for iga nephropathy3 Sep 2026US 2026/0259209 A1Buddhist Tzu Chi Medical Foundation
Most cited
By later US patents
- Therapeutic methods and agents for diseases associated with decreased expression of AOP-1 gene or AOP-193US 7,598,228 B2Asubio Pharma Co., Ltd. · 2009
- Method and kit for the early detection of impaired renal status37US 7,662,578 B2Children's Hospital Medical Center · 2010
- Apparatus and methods for diagnosing renal disorders37US 8,481,324 B2Technion Research & Development Foundation Limited · 2013
- Methods for detection of IL-18 as an early marker for diagnosis of acute renal failure and predictor of mortality35US 7,141,382 B12006
- Biomarkers of renal injury33US 10,557,856 B2University of Pittsburgh—Of the Commonwealth System of Higher Education · 2020